Latest news
Iconovo launches improved versions of nasal ICOone inhalers
Iconovo launches improved versions of nasal ICOone. Both inhalers are designed for high technical performance and to minimize the risk of user error.…
Iconovo receives order from Top-10 Pharma company for evaluation of multi-dose inhaler
Iconovo announces that it has received an order from a company revenue wise ranking among the top ten largest pharma companies in the world to evaluate…
Press releases
Dec 14, 2021, 10:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Dec 14, 2021, 10:30
News
IR
English
Corporate Information
Other Corporate Information
Nov 19, 2021, 07:18
News
IR
English
Regulatory
MAR
Corporate Information
Sales
Order
Nov 19, 2021, 07:18
News
IR
Swedish
Regulatory
MAR
Corporate Information
Sales
Order
Nov 15, 2021, 12:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Nov 15, 2021, 12:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Nov 01, 2021, 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Nov 01, 2021, 09:00
News
IR
English
Corporate Information
Other Corporate Information
Oct 29, 2021, 08:11
News
IR
English
Corporate Information
Other Corporate Information
Oct 28, 2021, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Sep 22, 2021, 15:15
News
IR
Swedish
Corporate Information
Other Corporate Information
Sep 20, 2021, 09:00
News
IR
English
Corporate Information
Other Corporate Information
Sep 20, 2021, 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Sep 15, 2021, 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Aug 26, 2021, 14:09
News
IR
English
Corporate Information
Other Corporate Information
Aug 26, 2021, 14:09
News
IR
Swedish
Corporate Information
Other Corporate Information
Aug 25, 2021, 08:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Aug 23, 2021, 11:04
News
IR
English
Corporate Information
Other Corporate Information
Aug 20, 2021, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q2
Jul 12, 2021, 09:00
News
IR
English
Regulatory
MAR
Corporate Information
Sales
Order
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
Interim CEO
Anders Månsson
Mail: anders.mansson@iconovo.se